France-based ophthalmic lenses, frames, and sunglasses provider EssilorLuxottica has agreed to acquire Optegra from UK-based private equity company MidEuropa.
Optegra, an integrated ophthalmology platform, operates in the Czech Republic, the Netherlands, Poland, Slovakia, and the UK.
The group, operating under the Optegra, Iris, and Lexum brands, manages over 70 eye hospitals and diagnostic facilities across Europe.
The facilities offer a range of ophthalmic treatments, including cataract surgery, glaucoma treatments, and laser eye surgery, supported by AI in pre- and post-operative stages.
EssilorLuxottica said the acquisition supports its med-tech strategy, focused on enhancing its digital and comprehensive patient journey offerings.
The transaction is expected to close in 2025, subject to receipt of regulatory approvals and satisfaction of customary conditions.
EssilorLuxottica chairman and CEO Francesco Milleri said: “With the acquisition of Optegra, we are stepping into a new frontier – one where comprehensive eyecare, advanced diagnostics, therapeutic interventions and surgical treatments come together in one seamless platform.
“We have the strategic assets to fuel this vision: an extensive distribution network with new clinical approaches, a smart eyewear offering with healthcare potential, and diagnostic capabilities that will be able to detect conditions ranging from neurodegenerative diseases to cardiovascular dysfunction.
“Optegra and its experienced doctors will bring new medical capabilities to our Group, enabling us to address patients’ needs with the most advanced vision care technologies and treatments in one trusted system that will anchor our med-tech aspirations.
“Powered by our growing AI and big data capabilities, we will be able to broaden our impact and deliver the most personalised and seamless patient journey.”
Optegra’s surgeons and dedicated medical teams established a strong reputation for quality care and clinical leadership since 2007.
Its network, which serves both publicly reimbursed and private-pay patients, makes Optegra a suitable addition to EssilorLuxottica’s expanding offerings.
The acquisition is expected to enhance Optegra’s ability to deliver advanced eyecare solutions worldwide.
It follows EssilorLuxottica’s acquisition of an 80% stake in Heidelberg Engineering, a Germany-based specialist in diagnostic solutions and healthcare IT for ophthalmology.
Optegra Eye Health Care CEO Peter Byloos said: “Joining forces with EssilorLuxottica marks a transformative chapter for Optegra.
“The partnership not only accelerates our growth potential but also enhances our ability to deliver advanced, digital and integrated eyecare solutions to all our patients.
“It also creates a significant opportunity for our clinical team, our staff and leadership to be part of a global and inspiring leader in vision care.”
MidEuropa managing partner Robert Knorr: “We believe EssilorLuxottica is the ideal partner to lead Optegra into its next phase of growth and innovation, and we wish them every success as they build on the strong foundation we have helped create.”
